Novartis Investigative Site

Middleburg Heights, Ohio 44130

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Ankylosing Spondylitis Clinical Trial
Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Ankylosing Spondylitis Clinical Trial
Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials